|
1
|
Lloyd-Jones D, Adams R, Carnethon M, De
Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund
K, et al: Heart disease and stroke statistics-2009 update: A report
from the American Heart Association Statistics Committee and Stroke
Statistics Subcommittee. Circulation. 119:480–486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Osborn JW, Fink GD, Sved AF, Toney GM and
Raizada MK: Circulating angiotensin II and dietary salt: Converging
signals for neurogenic hypertension. Curr Hypertens Rep. 9:228–235.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Das M, Pal S and Ghosh A: Angiotensin
converting enzyme gene polymorphism (insertion/deletion) and
hypertension in adult asian indians: A population-based Study from
Calcutta, India. Hum Biol. 80:303–312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Churchill PC: Second messengers in renin
secretion. Am J Physiol. 249:F175–F184. 1985.PubMed/NCBI
|
|
5
|
Kang G, Lee YR, Joo HK, Park MS, Kim CS,
Choi S and Jeon BH: Trichostatin a modulates angiotensin II-induced
vasoconstriction and blood pressure via inhibition of p66shc
activation. Korean J Physiol Pharmacol. 19:467–472. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brown EM and Macleod RJ: Extracellular
calcium sensing and extracellular calcium signaling. Nat Rev Mol
Cell Biol. 4:530–538. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang R, Xu C, Zhao W, Zhang JK, Yang B and
Wu L: Calcium and polyamine regulated calcium-sensing receptors in
cardiac tissues. Eur J Biochem. 270:2680–2688. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Molostvov G, James S, Fletcher S, Bennett
J, Lehnert H, Bland R and Zehnder D: Extracellular calcium-sensing
receptor is functionally expressed in human artery. Am J Physiol
Renal Physiol. 293:F946–F955. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qu YY, Jing H, Wang LM, Na T, Hua Z, Liu
YM, Zhen L, Qian F and Fang H: Reduced expression of the
extracellular calcium-sensing receptor (CaSR) is associated with
activation of the renin-angiotensin system (RAS) to promote
vascular remodeling in the pathogenesis of essential hypertension.
PLoS One. 11:e01574562016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weston AH, Absi M, Ward DT, Ohanian J,
Dodd RH, Dauban P, Petrel C, Ruat M and Edwards G: Evidence in
favor of a calcium-sensing receptor in arterial endothelial cells:
studies with calindol and Calhex 231. Cir Res. 97:391–398. 2005.
View Article : Google Scholar
|
|
11
|
Atchison DK, Ortiz-Capisano MC and
Beierwaltes WH: Acute activation of the calcium-sensing receptor
inhibits plasma renin activity in vivo. Am J Physiol Regul Integr
Comp Physiol. 299:R1020–R1026. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ayachi S: Increased dietary calcium lowers
blood pressure in the spontaneously hypertensive rat. Metabolism.
28:1234–1238. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cow D: Some reactions of surviving
arteries. J Physiol. 42:125–143. 1911. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ogata H, Ritz E, Odoni G, Amann K and Orth
SR: Beneficial effects of calcimimetics on progression of renal
failure and cardiovascular risk factors. J Am Soc Nephrol.
14:959–967. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rybczynska A, Lehmann A, Jurskajasko A,
Boblewski K, Orlewska C, Foks H and Drewnowska K: Hypertensive
effect of calcilytic NPS 2143 administration in rats. J Endocrinol.
191:189–195. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rybczynska A, Jurskajasko A, Boblewski K,
Lehmann A and Orlewska C: Blockade of calcium channels and AT1
receptor prevents the hypertensive effect of calcilytic NPS 2143 in
rats. J Physiol Pharmacol. 61:163–170. 2010.PubMed/NCBI
|
|
17
|
Ortiz-Capisano MC, Reddy M, Mendez M,
Garvin JL and Beierwaltes WH: Juxtaglomerular cell CaSR stimulation
decreases renin release via activation of the PLC/IP(3) pathway and
the ryanodine receptor. Am J Physiol Renal Physiol. 304:F248–F256.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maillard MP, Tedjani A, Perregaux C and
Burnier M: Calcium-sensing receptors modulate renin release in vivo
and in vitro in the rat. J Hypertens. 27:1980–1987. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Widdop RE and Li XC: A simple versatile
method for measuring tail cuff systolic blood pressure in conscious
rats. Clin Sci (Lond). 93:191–194. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rybczyńska A, Boblewski K, Lehmann A,
Orlewska C, Foks H, Drewnowska K and Hoppe A: Calcimimetic NPS
R-568 induces hypotensive effect in spontaneously hypertensive
rats. Am J Hypertens. 18:364–371. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakagawa K, Parekh N, Koleganova N, Ritz
E, Schaefer F and Schmitt CP: Acute cardiovascular effects of the
calcimimetic R-568 and its enantiomer S-568 in rats. Pediatr
Nephrol. 24:1385–1389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nemeth EF: Calcimimetic and calcilytic
drugs: Just for parathyroid cells? Cell Calcium. 35:283–289. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Renna NF, de Las Heras N and Miatello RM:
Pathophysiology of vascular remodeling in hypertension. Int J
Hypertens. 2013:8083532013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lan TH, Huang XQ and Tan HM: Vascular
fibrosis in atherosclerosis. Cardiovasc Pathol. 22:401–407. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beamish JA, He P and Marchant RE:
Molecular regulation of contractile smooth muscle cell phenotype:
Implications for vascular tissue engineering. Tissue Eng Part B
Rev. 16:467–491. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weber GF, Lett GS and Haubein NC:
Osteopontin is a marker for cancer aggressiveness and patient
survival. Br J Cancer. 103:861–869. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yi B, Cui J, Ning JN, Wang GS, Qian GS and
Lu KZ: Over-expression of PKGIα inhibits hypoxia-induced
proliferation, Akt activation and phenotype modulation of human
PASMCs: The role of phenotype modulation of PASMCs in pulmonary
vascular remodeling. Gene. 492:354–360. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ziegelstein RC, Xiong Y, He C and Hu Q:
Expression of a functional extracellular calcium-sensing receptor
in human aortic endothelial cells. Biochem Biophys Res Commun.
342:153–163. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Smajilovic S, Hansen JL, Christoffersen
TEH, Lewin E, Sheikh SP, Terwilliger EF, Brown EM, Haunso S and
Tfelt-Hansen J: Extracellular calcium sensing in rat aortic
vascular smooth muscle cells. Biochem Biophys Res Commun.
348:1215–1223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Smajilovic S, Yano S, Jabbari R and
Tfelt-Hansen J: The calcium-sensing receptor and calcimimetics in
blood pressure modulation. Br J Pharmacol. 164:884–893. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Alderman MH, Cohen HW, Sealey JE and
Laragh JH: Plasma renin activity levels in hypertensive persons:
Their wide range and lack of suppression in diabetic and in most
elderly patients. Am J Hypertens. 17:1–7. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Everett CM, Turner B and Lobo M: Posterior
reversible encephalopathy syndrome in (low renin) essential
hypertension. J R Soc Med. 100:522–523. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yuan W, Pan W, Kong J, Zheng W, Szeto FL,
Wong KE, Cohen R, Klopot A, Zhang Z and Li YC:
1,25-dihydroxyvitamin D3 suppresses renin gene transcription by
blocking the activity of the cyclic AMP response element in the
renin gene promoter. J Biol Chem. 282:29821–29830. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Joshi HB, Newns N, Stainthorpe A,
MacDonagh RP, Keeley FX Jr and Timoney AG: Ureteral stent symptom
questionnaire: Development and validation of a multidimensional
quality of life measure. J Urol. 169:1060–1064. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
de Gasparo M, Catt KJ, Inagami T, Wright
JW and Unger T: International union of pharmacology. XXIII. The
angiotensin II receptors. Pharmacol Rev. 52:415–472.
2000.PubMed/NCBI
|
|
36
|
Mogi M, Iwai M and Horiuchi M: New
insights into the regulation of angiotensin receptors. Curr Opin
Nephrol Hypertens. 18:138–143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Danser AH: Local renin-angiotensin
systems. Mol Cell Biochem. 157:211–216. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Singh VP, Le B, Bhat VB, Baker KM and
Kumar R: High-glucose-induced regulation of intracellular ANG II
synthesis and nuclear redistribution in cardiac myocytes. Am J
Physiol Heart Circ Physiol. 293:H939–H948. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Singh VP, Le B, Khode R, Baker KM and
Kumar R: Intracellular angiotensin ii production in diabetic rats
is correlated with cardiomyocyte apoptosis, oxidative stress and
cardiac fibrosis. Diabetes. 57:3297–3306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hunyady L and Catt KJ: Pleiotropic AT1
receptor signaling pathways mediating physiological and pathogenic
actions of angiotensin II. Mol Endocrinol. 20:953–970. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Blaine EH, Schorn TW and Boger J:
Statine-containing renin inhibitor. Dissociation of blood pressure
lowering and renin inhibition in sodium-deficient dogs.
Hypertension. 6:I111–I118. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Unger T, Ganten D, Lang RE and Schölkens
BA: Is tissue converting enzyme inhibition a determinant of the
antihypertensive efficacy of converting enzyme inhibitors? Studies
with the two different compounds, Hoe498 and MK421, in
spontaneously hypertensive rats. J Cardiovasc Pharmacol. 6:872–880.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J, Gao X, Zhang B, Kang L, Guo Z and
Fan G: Antagonistic effect of traditional Chinese medicine on RAS
changes in experimental hypertensive rats. Chin med New Drugs Clin
Pharmacol. 15:68–70. 2004.(In Chinese).
|
|
44
|
Ferrario CM, Jessup J, Chappell MC,
Averill DB, Brosnihan KB, Tallant EA, Diz DI and Gallagher PE:
Effect of angiotensin-converting enzyme inhibition and angiotensin
II receptor blockers on cardiac angiotensin-converting enzyme 2.
Circulation. 111:2605–2610. 2005. View Article : Google Scholar : PubMed/NCBI
|
